China & Japan will be covered more or less with FDA approval.
CE Mark will cover Europe including the UK. Sales should come once the CE Mark and EU certification is received. Hence, sales should be in the second half of 2019, obviously assuming CE Mark approval by June.
Sales should be good since it’s around US $25,000 per dose. This is not insignificant. Even 100 doses translates to $US 2.5 million. 1000 doses equates to $US 25 million. Again not insignificant considering the size of the market in Europe alone.
Even the relatively small Aussie market will be good to launch in.
And this even before US, China and Japan.
China & Japan will be covered more or less with FDA approval.CE...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.02 |
Change
0.020(2.00%) |
Mkt cap ! $14.50M | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.04 | 99.5¢ | $44.55K | 44.45K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 192 | $1.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.04 | 6234 | 1 |
View Market Depth
| Last trade - 15.48pm 25/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |